Announced
Synopsis
BRS & Co, a New York-based private equity firm, has agreed to invest in Organika Health Products, a Canadian manufacturer of nutritional supplements. Financial terms were not disclosed. “BRS’s track record of helping entrepreneur-owned businesses grow, combined with its past experience in nutritional supplements and the broader consumer products industry, will be invaluable in helping Organika achieve its long-term objectives.” Aaron Chin, Organika’s CEO.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.